Literature DB >> 26061371

A historical overview of leprosy epidemiology and control activities in Amazonas, Brazil.

Carolina Cunha1, Valderiza Lourenço Pedrosa1, Luiz Carlos Dias1, Andréa Braga2, Anette Chrusciak-Talhari2, Mônica Santos1, Gerson Oliveira Penna3, Sinésio Talhari4, Carolina Talhari1.   

Abstract

Leprosy is an ancient infectious disease caused by Mycobacterium leprae. According to comparative genomics studies, this disease originated in Eastern Africa or the Near East and spread with successive human migrations. The Europeans and North Africans introduced leprosy into West Africa and the Americas within the past 500 years. In Brazil, this disease arrived with the colonizers who disembarked at the first colonies, Rio de Janeiro, Salvador and Recife, at the end of the sixteenth century, after which it was spread to the other states. In 1854, the first leprosy cases were identified in State of Amazonas in the north of Brazil. The increasing number of leprosy cases and the need for treatment and disease control led to the creation of places to isolate patients, known as leprosaria. One of them, Colonia Antônio Aleixo was built in Amazonas in 1956 according to the most advanced recommendations for isolation at that time and was deactivated in 1979. The history of the Alfredo da Matta Center (AMC), which was the first leprosy dispensary created in 1955, parallels the history of leprosy in the state. Over the years, the AMC has become one of the best training centers for leprosy, general dermatology and sexually transmitted diseases in Brazil. In addition to being responsible for leprosy control programs in the state, the AMC has carried out training programs on leprosy diagnosis and treatment for health professionals in Manaus and other municipalities of the state, aiming to increase the coverage of leprosy control activities. This paper provides a historical overview of leprosy in State of Amazonas, which is an endemic state in Brazil.

Entities:  

Mesh:

Year:  2015        PMID: 26061371     DOI: 10.1590/0037-8682-0103-2013

Source DB:  PubMed          Journal:  Rev Soc Bras Med Trop        ISSN: 0037-8682            Impact factor:   1.581


  3 in total

1.  Impact of the COVID-19 pandemic on the diagnosis of leprosy in Brazil: An ecological and population-based study.

Authors:  Wandklebson Silva da Paz; Mariana do Rosário Souza; Débora Dos Santos Tavares; Amélia Ribeiro de Jesus; Allan Dantas Dos Santos; Rodrigo Feliciano do Carmo; Carlos Dornels Freire de Souza; Márcio Bezerra-Santos
Journal:  Lancet Reg Health Am       Date:  2022-01-15

2.  Measuring endemicity and burden of leprosy across countries and regions: A systematic review and Delphi survey.

Authors:  Dorcas O Ogunsumi; Vivek Lal; Karl Philipp Puchner; Wim van Brakel; Eva-Maria Schwienhorst-Stich; Christa Kasang; Joseph Chukwu; Saskia Kreibich; Sandra Parisi; Jan Hendrik Richardus; David J Blok
Journal:  PLoS Negl Trop Dis       Date:  2021-09-20

3.  Estimating underreporting of leprosy in Brazil using a Bayesian approach.

Authors:  Guilherme L de Oliveira; Juliane F Oliveira; Júlia M Pescarini; Roberto F S Andrade; Joilda S Nery; Maria Y Ichihara; Liam Smeeth; Elizabeth B Brickley; Maurício L Barreto; Gerson O Penna; Maria L F Penna; Mauro N Sanchez
Journal:  PLoS Negl Trop Dis       Date:  2021-08-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.